HEMGENIX ®, the first and only FDA-approved gene therapy for adults with hemophilia B, wins for Best Product for Rare/Orphan Diseases "CSL is humbled and honored to receive a Prix Galien award for ...
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...
Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
CSL, the leading European provider of critical IoT connectivity, is pleased to announce its strategic acquisition of EdgeConnect, a multi-award-winning specialist internet connectivity solutions ...
Hosted on MSN
Buffett backs CSL, Life360, WiseTech in latest move
CSL Limited is one of the world’s leading companies specializing in blood plasma therapies, nephrology, and vaccines. The company has an impressive track record of growth, driven by its commitment to ...
It’s often said that knowledge is power, and that’s never been more true for businesses than in today’s digital age. Technology tools enable businesses to collect a wealth of information from ...
It’s both an exciting and high-stakes time to be a tech leader. They’re expected to not only make the most of their current tech stacks, but also to know what new technology tools and services are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback